| GRIDSS: sensitive and specific genomic rearrangement detection using positional de Bruijn graph assembly DL Cameron, J Schröder, JS Penington, H Do, R Molania, A Dobrovic, ... Genome research 27 (12), 2050-2060, 2017 | 299 | 2017 |
| A new normalization for Nanostring nCounter gene expression data R Molania, JA Gagnon-Bartsch, A Dobrovic, TP Speed Nucleic acids research 47 (12), 6073-6083, 2019 | 83 | 2019 |
| The Hippo pathway oncoprotein YAP promotes melanoma cell invasion and spontaneous metastasis X Zhang, L Yang, P Szeto, GK Abali, Y Zhang, A Kulkarni, K Amarasinghe, ... Oncogene 39 (30), 5267-5281, 2020 | 65 | 2020 |
| Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells A Jayachandran, PH Lo, AC Chueh, P Prithviraj, R Molania, ... BMC cancer 16, 1-15, 2016 | 42 | 2016 |
| Multiple Myeloma DREAM Challenge reveals epigenetic regulator PHF19 as marker of aggressive disease MJ Mason, C Schinke, CLP Eng, F Towfic, F Gruber, A Dervan, BS White, ... Leukemia 34 (7), 1866-1874, 2020 | 40 | 2020 |
| Serum microRNA is a biomarker for post-operative monitoring in glioma A Morokoff, J Jones, H Nguyen, C Ma, A Lasocki, F Gaillard, I Bennett, ... Journal of neuro-oncology 149, 391-400, 2020 | 33 | 2020 |
| tidybulk: an R tidy framework for modular transcriptomic data analysis S Mangiola, R Molania, R Dong, MA Doyle, AT Papenfuss Genome biology 22, 1-15, 2021 | 27 | 2021 |
| Removing unwanted variation from large-scale RNA sequencing data with PRPS R Molania, M Foroutan, JA Gagnon-Bartsch, LC Gandolfo, A Jain, A Sinha, ... Nature Biotechnology 41 (1), 82-95, 2023 | 23 | 2023 |
| The ratio of exhausted to resident infiltrating lymphocytes is prognostic for colorectal cancer patient outcome M Foroutan, R Molania, A Pfefferle, C Behrenbruch, S Scheer, A Kallies, ... Cancer Immunology Research 9 (10), 1125-1140, 2021 | 22 | 2021 |
| Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES) PKH Lau, B Feran, L Smith, A Lasocki, R Molania, K Smith, A Weppler, ... Journal for Immunotherapy of Cancer 9 (10), 2021 | 20 | 2021 |
| LRH-1 expression patterns in breast cancer tissues are associated with tumour aggressiveness JMB Pang, R Molania, A Chand, K Knower, EA Takano, DJ Byrne, ... Oncotarget 8 (48), 83626, 2017 | 20 | 2017 |
| Reducing Artifactual EGFR T790M Mutations in DNA from Formalin-Fixed Paraffin-Embedded Tissue by Use of Thymine-DNA Glycosylase H Do, R Molania, PL Mitchell, R Vaiskunaite, JD Murdoch, A Dobrovic Clinical chemistry 63 (9), 1506-1514, 2017 | 17 | 2017 |
| Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast Cancer C Waryah, J Cursons, M Foroutan, C Pflueger, E Wang, R Molania, ... Advanced Science 10 (22), 2301802, 2023 | 10 | 2023 |
| Digital PCR of genomic rearrangements for monitoring circulating tumour DNA H Do, D Cameron, R Molania, B Thapa, G Rivalland, PL Mitchell, ... Circulating Nucleic Acids in Serum and Plasma–CNAPS IX, 139-146, 2016 | 9 | 2016 |
| A panel of Cancer testis antigens and clinical risk factors to predict metastasis in colorectal Cancer R Molania, F Mahjoubi, R Mirzaei, SR Khatami, B Mahjoubi Journal of biomarkers 2014, 2014 | 8 | 2014 |
| RUV-III-NB: Normalization of single cell RNA-seq Data A Salim, R Molania, J Wang, A De Livera, R Thijssen, TP Speed Nucleic Acids Research 50 (16), e96-e96, 2022 | 5 | 2022 |
| Evaluation of PAM50 intrinsic subtypes and risk of recurrence (ROR) scores in premenopausal women with early-stage HR+ breast cancer: A secondary analysis of the SOFT trial. LC Brown, SJ Luen, R Molania, F Caramia, P Savas, C VanGeelen, ... Journal of Clinical Oncology 41 (16_suppl), 504-504, 2023 | 4 | 2023 |
| ahctf1 and kras mutations combine to amplify oncogenic stress and restrict liver overgrowth in a zebrafish model of hepatocellular carcinoma KJ Morgan, K Doggett, F Geng, S Mieruszynski, L Whitehead, KA Smith, ... Elife 12, e73407, 2023 | 1 | 2023 |
| 1079MO Progression of BRAF mutant CNS metastases are associated with a transcriptional network bearing similarities with the innate PD-1 resistant signature (IPRES) PKH Lau, B Feran, L Smith, A Lasocki, R Molania, K Smith, A Weppler, ... Annals of Oncology 31, S733, 2020 | 1 | 2020 |
| Research briefing TP Speed, R Molania nature biotechnology 41, 27-28, 2023 | | 2023 |
